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Abstract
Background: Non-traumatic coma is a common acute childhood presentation to healthcare facilities in Africa and
is associated with high morbidity and mortality. Historically, the majority of cases were attributed to cerebral malaria
(CM). With the recent drastic reduction in malaria incidence, non-malarial coma is becoming a larger proportion of
cases and determining the aetiology is diagnostically challenging, particularly in resource-limited settings. The
purpose of this study will be to evaluate the aetiology and prognosis of non-traumatic coma in African children.
Methods: With no date restrictions, systematic searches of MEDLINE, Embase, and Scopus will identify prospective
and retrospective studies (including randomised controlled trials, cluster randomised trials, cohort studies, cross-
sectional, and case-control studies) recruiting children (1 month–16 years) with non-traumatic coma (defined by
Blantyre Coma Score ≤ 2 or comparable alternative) from any African country. Disease-specific studies will be
included if coma is associated and reported. The primary outcome is to determine the aetiology (infectious and
non-infectious) of non-traumatic coma in African children, with pooled prevalence estimates of causes (e.g.,
malaria). Secondary outcomes are to determine overall estimates of morbidity and mortality of all-cause non-
traumatic coma and disease-specific states of non-traumatic coma, where available. Random effects meta-analysis
will summarise aetiology data and in-hospital and post-discharge mortality. Heterogeneity will be quantified with τ2,
I2, and Cochran’s Q test.
Discussion: This systematic review will provide a summary of the best available evidence on the aetiology and
outcome of non-traumatic coma in African children.
Systematic review registration: PROSPERO CRD42020141937
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Background
Non-traumatic coma is a common acute childhood pres-
entation to healthcare facilities throughout Africa. Infec-
tious causes of deep coma (defined as Blantyre Coma
Scale (BCS) ≤ 2) include cerebral malaria (CM), acute
bacterial meningitis (ABM), viral encephalitides, and
HIV-associated opportunistic pathogens, such as tuber-
culosis and cryptococcal disease [1–3]. Non-infectious
causes of deep coma include metabolic abnormalities
and toxins [1–3]. In malaria-endemic regions, CM is di-
agnosed in children with coma and peripheral malaria
parasitaemia with no other identifiable cause [1]. Limited
diagnostic resources in many African settings and the
phenomenon of asymptomatic malaria parasitaemia have
rendered the alternate diagnoses of childhood coma
under-described, resulting in a poor epidemiological un-
derstanding of this clinical presentation [4, 5]. A study
in Kenya revealed that less than half of children admit-
ted with acute non-traumatic coma had an identified
cause [6]. With the recent drastic reduction in malaria
incidence, it is postulated that non-malarial coma repre-
sents a larger proportion of coma cases [6]. Non-
traumatic coma in children is associated with high mor-
tality (15–58%) and significant neurological sequelae
(31–68%) [7–9]. The long-term effects of coma on cog-
nition and educational achievement are less commonly
described, and existing literature primarily focuses on
CM [10, 11]. These effects, including neurological im-
pairment in cognitive and motor function, play an im-
portant role in the socioeconomic development of low-
resource countries [12].
There is a paucity of data on the aetiology of non-
malarial coma in Africa [3]. Given the high burden of
morbidity and mortality associated with this clinical
presentation, an overview of the literature to date is vital
to direct further research. Gwer et al. performed a litera-
ture review of fourteen single studies on childhood non-
traumatic coma in Africa and Asia [9]. Gwer et al. is the
only existing review investigating childhood non-
traumatic coma in Africa, and it does not include a for-
mal outcome analysis nor meta-analysis (on aetiology or
outcome). Gwer et al. also focused on all-cause non-
traumatic coma studies and did not explore severe coma
subgroups in single disease and/or pathogen studies for
outcome. Moreover, since the publication of Gwer et al.,
there have subsequently been a number of larger im-
portant studies using molecular diagnostics and other
adjuvant diagnostic capacities, such as magnetic reson-
ance imaging (MRI) and electroencephalogram (EEG).
Non-traumatic coma outcomes in Africa are
heterogenous between studies, and long-term follow-up
is sparse. A systematic review and meta-analysis on aeti-
ology and outcome of paediatric non-traumatic coma in
Africa is needed; it will substantially enrich accurate
estimates of both the proportions of individual causes of
non-traumatic coma and their associated morbidity and
mortality.
This is a systematic review and meta-analysis seeking
to evaluate the aetiology and prognosis of non-traumatic
coma in African children. Using an adapted population,
intervention, comparator, outcome, and study designs
(PICOS) framework, we will examine the best available
evidence on the aetiology of acute non-traumatic coma
in African children, including specific syndromic cohorts
in comatose children to broaden the search of studies
and maximise the evidence base [13]. Our adapted
framework will use the population (children with non-
traumatic coma), exposure (aetiology of infection and
covariates, e.g., HIV status and malnutrition), outcome
(morbidity and mortality), and study design framework.
Methods
Protocol development and registration
The present protocol has been registered within the
PROSPERO database (registration number
CRD42020141937) and is being reported in accordance
with the reporting guidance provided in the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses Protocols (PRISMA-P) statement [14] (see
checklist in Additional file 1). We will use elements of
the Cochrane Handbook of Systematic Reviews to guide
the conducting of the planned systematic review [15].
Outcomes of interest
The primary outcome of this study is to determine the
aetiology (infectious and non-infectious) of non-
traumatic coma in African children, with pooled preva-
lence estimates of causes (e.g., malaria). The secondary
outcomes are to determine the overall estimates of mor-
bidity (characterised as neurological sequelae or disabil-
ity (cognitive and/or motor) related to the illness) and
mortality of all-cause non-traumatic coma and disease-
specific states of non-traumatic coma, where available.
Eligibility criteria
We will consider for inclusion prospective and retro-
spective studies (randomised controlled trials, cluster
randomised trials, cohort studies, cross-sectional, and
case-control studies) recruiting children (1 month–16
years) with coma (defined by Blantyre Coma Score ≤ 2
or comparable alternative) from any African country.
Disease-specific studies (e.g., malaria) will be included
given that coma is associated and reported. Case reports,
case series, commentaries, and editorials will be ex-
cluded from the review, and we will exclude all publica-
tions that do not contain primary data. This rationale
for such a broad geographical and aetiological eligibility
is to ensure the most comprehensive investigation and
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analysis of non-traumatic coma (including disease-
specific studies) in African children to date.
Information sources and search strategy
We will search the MEDLINE, Embase, and Scopus da-
tabases with no date restrictions. A draft search strategy
for MEDLINE is available in Additional file 2. Searches
will be limited to English and French articles. We will
search conference proceedings and databases of ongoing
studies (including ClinicalTrials.gov, ISRCTN registry,
and the WHO ICTRP portal) to identify studies not
found in the databases listed above; grey literature will
not be included. When appropriate, attempts to contact
study authors for primary data will be made. Reference
lists of eligible studies and relevant systematic reviews
will be searched to identify additional studies to be con-
sidered for inclusion. All records identified from the
search will be imported to EndNote X9.3.1 (Clarivate
Analytics, Philadelphia, PA), a citation management
programme, following which duplicates will be removed.
Screening and selection criteria
Two authors (SR and CF) will independently screen the
title and abstract of each publication, and disagreements
will be resolved by consensus or third author (AB). We
will review a reference for the full text if this reference
includes (1) a mention of coma, children (1 month–16
years) and non-traumatic aetiology and (2) recruitment
in an African setting for which it is possible to disaggre-
gate a total number of children with non-traumatic
coma and possible to extract aetiology or outcome data.
Those articles which do not clearly meet the inclusion
criteria will be excluded. The number of records
screened and excluded will be recorded.
The full text of the identified studies will be individu-
ally assessed for eligibility against the predetermined cri-
teria by two reviewers (two out of CF, SR, and AB for
each article) in duplicate, with disagreements resolved
by consensus or third reviewer. Reasons for exclusion of
full-text articles will be documented. Articles will be
stored and managed in EndNote X9.3.1 (Clarivate
Analytics, Philadelphia, PA).
Data extraction
We will use the Cochrane Effective Practice and
Organisation of Care (EPOC) standard data collection
form and adapt it for study characteristics and out-
come data [17]. Two review authors will pilot the
form on a randomly selected subset of 10% of in-
cluded studies [15, 18]. Pilot testing of the forms will
include a computation of the reviewers’ reliability. Re-
viewers will extract data independently and in dupli-
cate from each eligible study. Attempts to contact
authors will be made to obtain missing outcome data
or other key study characteristics. The full data ex-
traction form can be found in Additional file 3.
Assessment of risk of bias
Three reviewers (CF, SR, and AB) will independently
conduct a bias risk assessment at the outcome and
study-level to assess the quality of included studies. The
revised Cochrane Risk-of-Bias tool (RoB 2.0) will be used
for assessing randomised controlled trials [16]. A modi-
fied Newcastle-Ottawa Scale (NOS), which incorporates
the Critical Appraisal Skills Programme (CASP) checklist
and Risk of Bias in Non-Randomized Studies of Inter-
ventions (ROBINS-I), will be used for all other study
types (Additional file 4) [19, 20]. Risk of bias for each
domain will be recorded as high (1), low (0), or unclear.
Any disagreements will be resolved by consensus or dis-
cussed with a fourth reviewer (MG) if consensus is not
achieved. The risk of bias for included studies will be de-
scribed throughout data synthesis.
Data synthesis
A narrative synthesis of the data will also be provided,
including a summary and explanation of characteristics
and key summary tables and findings of included studies
per outcome. For aetiology analyses, we will include all
studies regardless of coma definition, and we will include
usual care and intervention arms of RCTs. Heterogeneity
will be quantified with τ2, I2, and Cochran’s Q test [15].
Aetiology data will be summarised by random effects
meta-analysis. Because of concerns about meta-analysis
of proportions on very heterogeneous populations, we
also plan a meta-analysis of outcome stratified by inclu-
sion criteria (e.g., coma measure). Mortality will be pre-
sented as a simple proportion with exact binomial
confidence intervals, and pooled mortality estimates will
be calculated using generalised linear mixed models (a
normal-binomial model). For interventional studies, the
outcomes in the usual care arm of the study only will be
included in these estimates. There will also be a random
effects meta-analysis of in-hospital and post-discharge
mortality. Exploratory meta-regression will be under-
taken to explore heterogeneity by including covariates as
fixed effects (e.g. proportion of patients infected with
HIV and malnutrition) and testing for improved model
fit by likelihood ratio testing of nested models [21]. A p-
value of < 0.05 will be considered a statistically signifi-
cantly improved fit. Summary estimates of 1-month
mortality, where available, will be considered together
and presented in the same way. A sensitivity analysis will
be performed in a subgroup analysis of malaria only
including studies using Artemisinin derivatives.
Pooled prevalence estimates of malaria, acute bacterial
or viral meningitis, encephalitis, and bloodstream
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infection will be calculated using random effects meta-
analysis as above.
All studies will be included in the primary analysis.
To assess meta-biases, we will conduct Funnel plots
(when approximately ten studies are included in the
meta-analysis) with an Egger test on asymmetry at
alpha level 0.1 [22]. The strength of the body of evi-
dence will be assessed using the GRADE approach
[23]. Overall quality will be rated as high (further re-
search is unlikely to change our confidence in the es-
timate of the effect), medium (further research is
likely to have an impact on our confidence in the es-
timate of the effect), or low (further research is very
likely to have an impact on our confidence in the es-
timate of the effect). Subgroup analyses will include
meta-analysis of severe coma (very low coma score
on admission), less severe coma (higher coma score
on admission), and disease-specific aetiologies (mal-
aria, bacterial meningitis, viral meningitis or encephal-
itis, or blood stream infection). High-quality studies
— those graded low risk of bias across all domains —
will be defined for each study type. A sensitivity ana-
lysis will be performed only including studies classi-
fied as medium- and low-risk, and a separate
sensitivity analysis will be performed at the outcome-
level using only high-quality studies [15].
Discussion
We anticipate potential challenges in obtaining paper
copies of journal articles via library resources, due to
the effects of the SARS-CoV-2 pandemic on library
staffing. In the event of protocol amendments, a de-
scription of the change and rationale will be docu-
mented with the journal, with the date of
amendment.
There are some practical issues and limitations of
our review. At the study-level, it will not always be
possible to confidently ascertain depth of coma in
these children, as a valid coma scale (e.g. Glasgow
Coma Scale [GCS], BCS) is not always used in stud-
ies. At the review-level, more papers will likely be set
in research centres and university hospitals, and fewer
papers will be set at rural and district hospitals and
clinics. Due to the endemicity of infectious febrile
coma aetiologies (e.g. CM, ABM), more papers will
likely be set in sub-Saharan Africa than North Africa.
Together, these may lead to urban and regional
biases. Lastly, included studies are limited to English
and French, which may exclude papers written in
other languages spoken throughout the continent.
This systematic review and meta-analysis will provide
a transparent review of the available evidence to provide
a more accurate understanding of the causes and out-
comes of non-traumatic coma in African children. We
seek to publish our results in a peer-reviewed journal,
attend conferences, and inform relevant parties in the
field of our findings. We hope that this review will raise
awareness of this common presentation in African set-
tings. This review will highlight gaps in the literature
and areas in which future research is required.
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